Delivering on the promise: HPV vaccines and cervical cancer

This publication has 42 references indexed in Scilit:

• Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers
  Vaccine, 2003
• Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants
  Journal of Virology, 2003
• A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine
  International Journal of Cancer, 2003
• Awareness of human papillomavirus among women attending a well woman clinic
  Sexually Transmitted Infections, 2003
• Trachea, Lung, and Tracheobronchial Lymph Nodes Are the Major Sites Where Antigen-Presenting Cells Are Detected after Nasal Vaccination of Mice with Human Papillomavirus Type 16 Virus-Like Particles
  Journal of Virology, 2002
• The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus Vaccine
  Epidemiology, 2002
• Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine
  Journal of Virology, 2002
• Neutralization of Human Papillomavirus Type 11 (HPV‐11) by Serum from Women Vaccinated with Yeast‐Derived HPV‐11 L1 Virus‐like Particles: Correlation with Competitive Radioimmunoassay Titer
  The Journal of Infectious Diseases, 2001
• Human papillomavirus life cycle: active and latent phases
  Seminars in Cancer Biology, 1999
• Declining Prevalence of Cervicovaginal Human Papillomavirus Infection With Age Is Independent of Other Risk Factors
  Sexually Transmitted Diseases, 1996